Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Early activation of CD4+ and CD8+ T lymphocytes by myelin basic protein in subjects with MS.
Early bilateral cystoid macular oedema secondary to fingolimod in multiple sclerosis.
Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study.
Delayed onset adenosine deaminase deficiency associated with acute disseminated encephalomyelitis.
Tysabri
Nav1.5 sodium channels in macrophages in multiple sclerosis lesions.
Tysabri prescribing information
Genome-wide association study of multiple sclerosis confirms a novel locus at 5p13.1.
Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease.
Opposing Effects of Membrane-Anchored CX3CL1 on Amyloid and Tau Pathologies via the p38 MAPK Pathway.
Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients.
Lodonal/LDN
Oligodendrocytes and the early multiple sclerosis lesion.
[Pharmacological properties and clinical efficacy of fingolimod hydrochloride (Imusera®/Gilenya®) for the treatment of multiple sclerosis].
Physiopathology of symptoms and signs in multiple sclerosis.
Focused suggestion with somatic anchoring technique: rapid self-hypnosis for pain management.
Genetic analysis of the aquaporin-4 gene for anti-AQP4 antibody-positive neuromyelitis optica in a Japanese population.
Fulminant Central Nervous System Nocardiosis in a Patient Treated With Alemtuzumab For Relapsing-Remitting Multiple Sclerosis.
Two discreet subsets of CD8 T cells modulate PLP(91-110) induced experimental autoimmune encephalomyelitis in HLA-DR3 transgenic mice.
Autoinflammatory grey matter lesions in humans: cortical encephalitis, clinical disorders, experimental models.
High risk of MS in Iranian immigrants in Gothenburg, Sweden.
Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients.
Optic neuritis in a child with biotinidase deficiency: case report and literature review.
Successful desensitization to natalizumab in a skin test--positive patient: a case report.
Bridging the Brain Disease Knowledge Gap Through Computational Modeling and Systems Biology
Pages
« first
‹ previous
…
151
152
153
154
155
156
157
158
159
…
next ›
last »